Transoral robotic supraglottic laryngectomy: Long-term functional and oncologic outcomes

dc.authorid0000-0001-7992-0974
dc.authorid0000-0003-4014-8176
dc.contributor.authorMuderris, Togay
dc.contributor.authorSevil, Ergun
dc.contributor.authorGul, Fatih
dc.date.accessioned2026-01-24T12:31:04Z
dc.date.available2026-01-24T12:31:04Z
dc.date.issued2024
dc.departmentAlanya Alaaddin Keykubat Üniversitesi
dc.description.abstractObjectives: Minimally invasive transoral organ preservation surgeries are being increasingly used for supraglottic tumors. This study investigates the long-term functional and oncologic outcomes of transoral robotic supraglottic laryngectomy (TORS-SGL).Materials and methods: Twenty-three patients with supraglottic laryngeal cancer who underwent TORS-SGL be-tween 2012 and 2015 at a tertiary referral hospital were retrospectively analyzed with at least 5 years of follow-up. The head and neck tumor council and the multidisciplinary oncological board decided whether the patients were suitable for robotic surgery, and the necessity of adjuvant radiotherapy or chemotherapy. Inclusion criteria was histopathological diagnosis of squamous cell carcinoma of the larynx.Results: Twenty-one patients with T1-T3 supraglottic squamous cell carcinoma were included in this study. Mean follow-up was 48.8 months. Local control was 94.4 % at 2 years and 85.9 % at 5 years. Disease-free survival and overall survival were 85.7 % and 81 % at 2 years and 69.3 % and 57.1 % at 5 years, respectively. There was no permanent tracheostomy or prolonged swallowing dysfunction among patients. Age, perineural and lympho-vascular invasion were found to be risk factors affecting overall survival.Conclusion: TORS-SGL is a feasible, safe and reliable approach with excellent functional results for T1, T2, and selected T3 supraglottic tumors, providing acceptable long-term oncologic results when compared to alternative treatment modalities.
dc.identifier.doi10.1016/j.amjoto.2023.104105
dc.identifier.issn0196-0709
dc.identifier.issn1532-818X
dc.identifier.issue1
dc.identifier.pmid37977058
dc.identifier.urihttps://doi.org/10.1016/j.amjoto.2023.104105
dc.identifier.urihttps://hdl.handle.net/20.500.12868/5632
dc.identifier.volume45
dc.identifier.wosWOS:001119017500001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherW B Saunders Co-Elsevier Inc
dc.relation.ispartofAmerican Journal of Otolaryngology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260121
dc.subjectTransoral robotic surgery
dc.subjectSupraglottic laryngectomy
dc.subjectLaryngeal cancer
dc.subjectSurvival
dc.subjectFunctional outcomes
dc.titleTransoral robotic supraglottic laryngectomy: Long-term functional and oncologic outcomes
dc.typeArticle

Dosyalar